Morfit G Mason
Insider CIK 1325920 · CRM Director · MSFT Director · VRX Director · BCR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRM Salesforce, Inc. | P Buy | 2025-12-05 | 2025-12-08 | 96,000 | $260.58 | $25.02M | 2,994,509 | SEC↗ |
| CRM Salesforce, Inc. | S Sale | 2024-12-20 | 2024-12-20 | 15,353 | $340.55 | $5.23M | 2,898,509 | SEC↗ |
| CRM Salesforce, Inc. | S Sale | 2024-12-19 | 2024-12-20 | 278,147 | $340.72 | $94.77M | 2,913,862 | SEC↗ |
| CRM Salesforce, Inc. | S Sale | 2024-12-18 | 2024-12-20 | 722,300 | $346.11 | $250.00M | 3,192,009 | SEC↗ |
| CRM Salesforce, Inc. | P Buy | 2024-06-03 | 2024-06-05 | 428,000 | $233.17 | $99.80M | 3,914,309 | SEC↗ |
| CRM Salesforce, Inc. | M Exercise deriv | 2023-11-22 | 2023-11-27 | 555 | — | $0 | 0 | SEC↗ |
| CRM Salesforce, Inc. | M Exercise | 2023-11-22 | 2023-11-27 | 555 | — | $0 | 1,663 | SEC↗ |
| CRM Salesforce, Inc. | M Exercise deriv | 2023-08-22 | 2023-08-23 | 554 | — | $0 | 555 | SEC↗ |
| CRM Salesforce, Inc. | M Exercise | 2023-08-22 | 2023-08-23 | 554 | — | $0 | 1,108 | SEC↗ |
| CRM Salesforce, Inc. | M Exercise deriv | 2023-05-22 | 2023-05-23 | 554 | — | $0 | 1,109 | SEC↗ |
| CRM Salesforce, Inc. | M Exercise | 2023-05-22 | 2023-05-23 | 554 | — | $0 | 554 | SEC↗ |
| CRM Salesforce, Inc. | A Award deriv | 2023-04-01 | 2023-04-03 | 1,663 | — | $0 | 1,663 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2017-11-28 | 2017-11-30 | 589 | — | $0 | 589 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2017-08-30 | 2017-08-31 | 675 | — | $0 | 675 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-08-08 | 2017-08-08 | 278,000 | $72.50 | $20.16M | 8,130,850 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-08-08 | 2017-08-08 | 30,169 | $72.50 | $2.19M | 881,949 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-08-07 | 2017-08-08 | 2,879,500 | $72.50 | $208.76M | 8,408,850 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-08-07 | 2017-08-08 | 312,331 | $72.50 | $22.64M | 912,118 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-08-04 | 2017-08-08 | 342,600 | $72.61 | $24.88M | 1,224,449 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-08-04 | 2017-08-08 | 3,157,400 | $72.61 | $229.26M | 11,288,350 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2017-05-30 | 2017-05-31 | 710 | — | $0 | 710 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-05-04 | 2017-05-05 | 391,500 | $68.82 | $26.94M | 1,567,049 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-05-04 | 2017-05-05 | 3,608,500 | $68.82 | $248.34M | 14,445,040 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-05-03 | 2017-05-05 | 293,600 | $68.89 | $20.23M | 1,958,549 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-05-03 | 2017-05-05 | 2,706,400 | $68.89 | $186.44M | 18,053,540 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-23 | 2017-02-23 | 1,172,800 | $64.46 | $75.60M | 20,758,348 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-23 | 2017-02-23 | 127,200 | $64.46 | $8.20M | 2,252,149 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-22 | 2017-02-23 | 1,443,400 | $64.23 | $92.71M | 21,931,148 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-22 | 2017-02-23 | 156,600 | $64.23 | $10.06M | 2,379,349 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-21 | 2017-02-23 | 167,900 | $64.52 | $10.83M | 2,535,949 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-21 | 2017-02-23 | 1,548,100 | $64.52 | $99.88M | 23,374,548 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-03 | 2017-02-03 | 1,804,300 | $63.33 | $114.27M | 24,922,648 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-03 | 2017-02-03 | 195,700 | $63.33 | $12.39M | 2,703,849 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-02 | 2017-02-03 | 5,412,800 | $63.12 | $341.66M | 26,726,948 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-02 | 2017-02-03 | 587,200 | $63.12 | $37.06M | 2,899,549 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-01 | 2017-02-03 | 2,706,400 | $63.72 | $172.45M | 32,139,748 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2017-02-01 | 2017-02-03 | 293,600 | $63.72 | $18.71M | 3,486,749 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2017-01-31 | 2017-02-01 | 773 | — | $0 | 1,592 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2016-11-29 | 2016-12-01 | 819 | — | $0 | 819 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2016-09-02 | 2016-09-06 | 867 | — | $0 | 1,819 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2016-07-28 | 2016-07-29 | 9,922,000 | $55.95 | $555.14M | 34,844,329 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2016-07-28 | 2016-07-29 | 1,078,000 | $55.95 | $60.31M | 3,780,349 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2016-07-27 | 2016-07-29 | 6,314,000 | $56.38 | $355.98M | 44,766,329 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2016-07-27 | 2016-07-29 | 686,000 | $56.38 | $38.68M | 4,858,349 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2016-06-02 | 2016-06-03 | 952 | — | $0 | 952 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2016-01-29 | 2016-02-01 | 908 | — | $0 | 908 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2015-12-01 | 2015-12-03 | 679 | — | $0 | 679 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2015-11-11 | 2015-11-12 | 2,390,520 | $53.74 | $128.47M | 51,078,742 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2015-11-11 | 2015-11-12 | 259,480 | $53.74 | $13.94M | 5,544,349 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2015-11-10 | 2015-11-12 | 14,433,328 | $53.49 | $772.04M | 53,469,262 | SEC↗ |
| MSFT MICROSOFT CORP | S Sale | 2015-11-10 | 2015-11-12 | 1,566,672 | $53.49 | $83.80M | 5,803,829 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-10-25 | 2016-05-10 | 1,883 | — | $0 | 1,883 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2015-10-23 | 2016-05-09 | 1,883 | — | $0 | 1,883 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2015-09-03 | 2015-09-04 | 862 | — | $0 | 862 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2015-06-03 | 2015-06-04 | 800 | — | $0 | 800 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2015-02-04 | 2015-02-04 | 106,258 | $41.42 | $4.40M | 67,500,000 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2015-02-04 | 2015-02-04 | 200,000 | $41.47 | $8.29M | 67,700,000 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2015-02-04 | 2015-02-04 | 200,000 | $41.49 | $8.30M | 67,900,000 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2015-02-02 | 2015-02-04 | 151,000 | $40.79 | $6.16M | 67,018,742 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2015-02-02 | 2015-02-04 | 100,000 | $40.79 | $4.08M | 67,118,742 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2015-02-02 | 2015-02-04 | 200,000 | $40.88 | $8.18M | 67,318,742 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2015-02-02 | 2015-02-04 | 75,000 | $40.93 | $3.07M | 67,393,742 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2015-01-30 | 2015-02-02 | 928 | — | $0 | 928 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2014-12-02 | 2014-12-03 | 774 | — | $0 | 774 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2014-08-19 | 2014-08-20 | 827 | — | $0 | 827 | SEC↗ |
| MSFT MICROSOFT CORP | J Other | 2014-06-05 | 2014-06-09 | 611 | — | $0 | 0 | SEC↗ |
| MSFT MICROSOFT CORP | A Award | 2014-05-19 | 2014-05-20 | 611 | — | $0 | 611 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2014-05-09 | 2014-05-12 | 500,000 | $39.59 | $19.80M | 7,370,501 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2014-05-09 | 2014-05-12 | 463,000 | $39.54 | $18.31M | 5,470,501 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2014-05-09 | 2014-05-12 | 600,000 | $39.58 | $23.75M | 6,870,501 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2014-05-09 | 2014-05-12 | 800,000 | $39.56 | $31.65M | 6,270,501 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2014-05-08 | 2014-05-12 | 287,501 | $39.50 | $11.36M | 5,007,501 | SEC↗ |
| MSFT MICROSOFT CORP | P Buy | 2014-05-08 | 2014-05-12 | 300,000 | $39.49 | $11.85M | 4,720,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-06-19 | 2013-06-21 | 1,352,941 | $85.00 | $115.00M | 1,352,941 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-06-04 | 2013-06-06 | 1,360 | $88.21 | $120.0K | 16,656 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer deriv | 2013-05-30 | 2013-06-03 | 1,319 | $90.81 | $119.8K | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer | 2013-05-30 | 2013-06-03 | 68,112 | $90.81 | $6.19M | 18,016 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-05-24 | 2013-05-29 | 5,022 | — | $0 | 86,128 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-17 | 2013-04-19 | 10,973 | $101.14 | $1.11M | 2,861,380 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-17 | 2013-04-25 | 10,973 | $101.14 | $1.11M | 2,861,380 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-16 | 2013-04-16 | 100,000 | $101.68 | $10.17M | 2,872,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-15 | 2013-04-16 | 100,000 | $102.51 | $10.25M | 2,972,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-12 | 2013-04-16 | 100,000 | $103.01 | $10.30M | 3,072,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-11 | 2013-04-11 | 100,000 | $103.02 | $10.30M | 3,172,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-10 | 2013-04-11 | 100,000 | $102.87 | $10.29M | 3,272,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-09 | 2013-04-11 | 100,000 | $101.53 | $10.15M | 3,372,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-04 | 2013-04-04 | 100,000 | $101.13 | $10.11M | 3,472,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-03 | 2013-04-04 | 32,749 | $101.05 | $3.31M | 3,572,353 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-04-02 | 2013-04-04 | 11,206 | $101.03 | $1.13M | 3,605,102 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-28 | 2013-04-01 | 8,148 | $101.01 | $823.0K | 3,616,308 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-21 | 2013-03-25 | 1,700 | $101.00 | $171.7K | 3,624,456 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-20 | 2013-03-20 | 14,782 | $101.12 | $1.49M | 3,626,156 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-19 | 2013-03-20 | 61,290 | $101.33 | $6.21M | 3,640,938 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-18 | 2013-03-20 | 100,000 | $101.32 | $10.13M | 3,702,228 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-15 | 2013-03-15 | 100,000 | $101.64 | $10.16M | 3,802,228 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-14 | 2013-03-15 | 100,000 | $101.51 | $10.15M | 3,902,228 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-13 | 2013-03-15 | 100,000 | $101.14 | $10.11M | 4,002,228 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-12 | 2013-03-12 | 100,000 | $101.11 | $10.11M | 4,102,228 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-11 | 2013-03-12 | 695 | $101.01 | $70.2K | 4,202,228 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2013-03-08 | 2013-03-12 | 77,671 | $101.17 | $7.86M | 4,202,923 | SEC↗ |
| BCR BARD C R INC /NJ/ | A Award deriv | 2012-12-12 | 2012-12-14 | 715 | — | $0 | 715 | SEC↗ |
| BCR BARD C R INC /NJ/ | A Award | 2012-12-12 | 2012-12-14 | 584 | — | $0 | 984 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-10-03 | 2012-10-03 | 81,543 | $105.25 | $8.58M | 4,280,594 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-10-02 | 2012-10-03 | 100,000 | $105.06 | $10.51M | 4,362,137 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-10-01 | 2012-10-01 | 100,000 | $105.08 | $10.51M | 4,462,137 | SEC↗ |
| BCR BARD C R INC /NJ/ | A Award | 2012-10-01 | 2012-10-03 | 400 | — | $0 | 400 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-09-27 | 2012-10-01 | 10,161 | $105.00 | $1.07M | 4,562,137 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-09-26 | 2012-09-26 | 15,929 | $105.02 | $1.67M | 4,572,298 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-09-25 | 2012-09-26 | 92,367 | $105.37 | $9.73M | 4,588,227 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-09-24 | 2012-09-26 | 100,000 | $105.34 | $10.53M | 4,680,594 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-08-01 | 2012-08-03 | 605 | $98.00 | $59.3K | 5,530,594 | SEC↗ |
| BCR BARD C R INC /NJ/ | S Sale | 2012-08-01 | 2012-08-03 | 750,000 | $95.50 | $71.63M | 4,780,594 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-06-04 | 2012-06-06 | 8,062 | — | $0 | 81,106 | SEC↗ |